Live
- Three persons admitted to hospital for diarrhea treatment
- First Star Outside Milky Way Captured: WOH G64 is 2,000 Times Larger Than the Sun
- Sikkim govt to constitute state Niti Ayog: CM Tamang
- CBI books Rajasthan narcotics inspector for Rs 3 lakh bribe
- Rajasthan bypolls: A tough contest between BJP and Congress
- Albania joins SEPA, paving way for EU integration
- Japanese government approves 250-billion USD economic package to ease price pain
- Six pharma companies to set up their units in Telangana
- The Unstable Events of a 17-Wicket Day in Perth: India vs Australia
- Dutch FM's Israel trip cancelled after Netanyahu's arrest warrant
Govt mulls bulk drug policy
Government Mulls Bulk Drug Policy. In a bid to counter the China’s aggression on bulk drug sector, the government is fast working out an exclusive ‘bulk drug policy’, according to BK Singh, Director, Department of Pharmaceuticals.
Govt offers finance to develop infrastructure at brown field clusters
Hyderabad: In a bid to counter the China’s aggression on bulk drug sector, the government is fast working out an exclusive ‘bulk drug policy’, according to BK Singh, Director, Department of Pharmaceuticals. “All the governmental departments engaged in regulating the pharmaceutical sector will be brought under single umbrella. The process is already on,” Singh told reporters on the sidelines of an interactive session organised by Confederation of Indian Industry (CII) here. However, he did not specify when the government will announce the policy.
Singh said the senior officials from the department are holding deliberations with the industry groups, manufacturing and trading associations in order to find out the problems being faced by the industry. Addressing the bulk drug producers in Hyderabad, Singh said the government is seriously looking for a solution to the China’s dumping of various pharmaceutical products into India.
“We know the problem and the root of the problem lies with the pricing. China could supply bulk drugs at a cheaper rate than ours. Indian pharma industry needs to be more competitive to counter the dumping,” he pointed out.
Singh felt that any amount of anti-dumping laws and levies will not work and it is not a solution. “When we impose anti-dumping duty on bulk drugs, they are introducing intermediates at lower rates,” he said. The interactive session was organised by CII here on Friday in association with Bulk Drug Manufacturers Association (BDMA) and Pharmaceutical Export Promotion Council of India (Pharmexcil). The session was attended by about 100 members from the Pharmaceutical fraternity. A solution the government found, according to him, will be improving the infrastructure (in technological terms) for the industry. The government has come up with a scheme to support the pharmaceutical clusters in providing various infrastructure requirements, if the clusters come in a group. Some of the infrastructure projects suggested are: CETP facility, Common Laboratories, effluent treatment, water treatment etc. These facilities would upgrade the industrial cluster on par with the international standards.
“Government is ready to fund about 50 per cent of the cost, with cap on the total amount to Rs 20 crore per project. We have earmarked Rs 125 crore in the next three years for the purpose,” Singh said.
